Abstract
Objective
Dermatofibrosarcoma protuberans (DFSP) is a relatively rare cutaneous soft tissue tumor that is locally aggressive, characterized by high rates of local recurrence, but low risk of metastasis. Wide radical excision is the preferred treatment for DFSP, but local recurrence rates of up to 60% after surgery alone have been documented in cases of close or compromised margin. Adjuvant radiotherapy has been used to reduce such recurrences.
Methods
A retrospective audit of patients of DFSP in two tertiary care hospitals of eastern India treated radically by surgery with or without adjuvant radiotherapy was undertaken. A cohort of 16 patients receiving treatment between January 2010 and December 2015 was evaluated for presentation, diagnosis, treatment, local control, toxicity, and disease-free survival.
Results
The mean age of presentation was 46 years with the range from 17 to 71 years, with 9 out of 16 being females. All patients underwent wide local excision except in two cases, with 8 patients undergoing re-resections after initial excision biopsy. A total of 12 out of 16 patients had less than 2-cm margin, and six had close deep resection margin. Of 16 patients, 10 received adjuvant radiotherapy. With the median follow-up of 39 months, four patients have developed recurrence, three in the surgical cohort and one in the radiotherapy cohort. Two patients in the surgical cohort who have developed recurrence had excision with close margin, and use of postoperative radiotherapy in them was withheld in view of increased risk of toxicity.
Conclusion
Combined modality therapy with surgery and radiotherapy for cases of close or inadequate margin results in good local control with acceptable toxicity, in cases where re-surgery is not possible or not contemplated.
Similar content being viewed by others
References
Chang CK, Jacobs IA, Salti GI (2004) Outcomes of surgery for dermatofibrosarcoma protuberans. Eur J Surg Oncol 30:341–345
Mendenhall WM, Zlotecki RA, Scarborough MT (2004) Dermatofibrosarcoma protuberans. Cancer. 101:2503–2508
Bogucki B, Neuhaus I, Hurst EA (2012) Dermatofibrosarcoma protuberans: a review of the literature. Dermatol Surg
Lindner NJ, Scarborough MT, Powell GJ, Spanier S, Enneking WF (1999) Revision surgery in dermatofibrosarcoma protuberans of the trunk and extremities. Eur J Surg Oncol 25:392–397
Fujimoto M, Kikuchi K, Okochi H, Furue M (1998) Atrophic dermatofibrosarcoma protuberans: a case report and review of the literature. Dermatology 196:422–424
MacKie RM (1992) Soft tissue tumors. In: Champion RH, Burton JL, Ebling FJG (eds) Textbook of dermatology, 5th edn. Blackwell, London, pp 2073–2100
Ratner D, Thomas CO, Johnson TM, Sondak VK, Hamilton TA, Nelson BR, Swanson NA, Garcia C, Clark RE, Grande DJ (1997) Mohs micrographic surgery for the treatment of dermatofibrosarcoma protuberans. Results of a multiinstitutional series with an analysis of the extent of microscopic spread. J Am Acad Dermatol 37:600–613
Sun LM, Wang CJ, Huang CC, Leung SW, Chen HC, Fang FM, Huang EY, Lee SP (2000) Dermatofibrosarcoma protuberans: treatment results of 35 cases. Radiother Oncol 57:175–181
Dagan R, Morris CG, Zlotecki RA, Scarborough MT, Mendenhall WM (2005) Radiotherapy in the treatment of dermatofibrosarcoma protuberans. Am J Clin Oncol 28(6):537–539
Williams N, Morris CG, Kirwan JM, Dagan R, Mendenhall WM (2014) Radiotherapy for Dermatofibrosarcoma Protuberans. Am J Clin Oncol 37(5):430–432
Joiner MC, Van der Kogel AJ (1997) The linear quadratic approach to fractionation and calculation of iso effect relationships. In: Steel GG (ed) Basic clinical radiobiology. Oxford University Press, New York, pp 106–112
Enzinger FM, Weiss SW (1988) Fibrohistiocytic tumors of intermediate malignancy. In: Stamathis G (ed) Soft tissue tumors. Mosby, St. Louis, pp 252–268
Bowne WB, Antonescu CR, Leung DH, Katz SC, Hawkins WG, Woodruff JM, Brennan MF, Lewis JJ (2000) Dermatofibrosarcoma protuberans. A clinicopathologic analysis of patients treated and followed at a single institution. Cancer. 88:2711–2720
Rutgers EJ, Kroon BB, Albus-Lutter CE, Gortzak E (1992) Dermatofibrosarcoma protuberans: treatment and prognosis. Eur J Surg Oncol 18:241–248
Fiore M, Miceli R, Mussi C, Lo Vullo S, Mariani L, Lozza L, Collini P, Olmi P, Casali PG, Gronchi A (2005) Dermatofibrosarcoma protuberans treated at a single institution: a surgical disease with a high cure rate. J Clin Oncol 23:7669–7675
Fields RC, Hameed M, Qin LX, Moraco N, Jia X, Maki RG, Singer S, Brennan MF (2011) Dermatofibrosarcoma protuberans (DFSP): predictors of recurrence and the use of systemic therapy. Ann Surg Oncol 18:328–336
Farma JM, Ammori JB, Zager JS, Marzban SS, Bui MM, Bichakjian CK, Johnson TM, Lowe L, Sabel MS, Wong SL, Douglas Letson G, Messina JL, Cimmino VM, Sondak VK (2010) Dermatofibrosarcoma protuberans: how wide should we resect? Ann Surg Oncol 17:2112–2118
Castle KO, Guadagnolo BA, Tsai CJ, Feig BW, Zagars GK Dermatofibrosarcoma Protuberans: Long-term Outcomes of 53 Patients Treated With Conservative Surgery and Radiation Therapy. Int J Radiat Oncol Biol Phys 86(3):585–590
Snow SN, Gordon EM, Larson PO, Bagheri MM, Bentz ML, Sable DB (2004) Dermatofibrosarcoma Protuberans: a report on 29 patients treated by Mohs micrographic surgery with long-term follow-up and review of the literature. Cancer. 101(1):28–38
Sondak VK, Cimmino VM, Lowe LM, Dubay DA (1999) JohnsonTM. Dermatofibrosarcoma protuberans: what is the best surgical approach? Surg Oncol 8:183–189
Ballo MT, Zagars GK, Pisters P, Pollack A (1998) The role of radiation therapy in the management of dermatofibrosarcoma protuberans. Int J Radiat Oncol Biol Phys 40(4):823–827
Mukherji A, Sinnatamby M (2017) Malignant soft tissue sarcoma of the shoulder treated by surface mould brachytherapy boost in an adjuvant setting. J Contemp Brachytherapy 9(2):167–173
Bandyopadhyay A, Basu P, Biswas S, Ghosh S Dermatofibrosarcoma protruberans of the scalp treated with customised surface mould high-dose-rate (HDR) brachytherapy: a case report. J Radiother Pract 17(4):455–459
McArthur GA, Demetri GD, van Oosterom A et al (2005) Molecular and clinical analysis of locally advanced dermatofibrosarcoma protuberans treated with imatinib: Imatinib Target Exploration Consortium Study B2225. J Clin Oncol 23:866–873
Han A, Chen EH, Niedt G et al (2009) Neoadjuvant Imatinib therapy for Dermatofibrosarcoma Protuberans. Arch Dermatol 145(7):792–796
Misset J, Kerob D, Porcher R et al (2007) Imatinib mesylate as a preoperative therapy in dermatofibrosarcoma: result of a multicentric phase II study on 25 patients. J Clin Oncol 25(18S):10032
DuBay D, Cimmino V, Lowe L, Johnson TM, Sondak VK (2004) Low recurrence rate after surgery for dermatofibrosarcoma protuberans: a multidisciplinary approach from a single institution. Cancer. 100(5):1008–1016
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008.
Informed consent
For this type of study formal consent is not required.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Bandyopadhyay, A., Biswas, S., Sepai, H.M. et al. Outcome of surgery and radiotherapy for dermatofibrosarcoma protuberans: 5-year experience from two tertiary centers of eastern India. J Radiat Oncol 8, 405–412 (2019). https://doi.org/10.1007/s13566-020-00412-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13566-020-00412-4